Cargando…

A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma

Objectives: Immunostimulatory therapies using immune checkpoint blockers show clinical activity in a subset of glioblastoma (GBM) patients. Several inhibitory mechanisms play a relevant role in the immune response to GBM. With the objective of analyzing the tumor immune microenvironment and its clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Idoate Gastearena, Miguel A., López-Janeiro, Álvaro, Lecumberri Aznarez, Arturo, Arana-Iñiguez, Iñigo, Guillén-Grima, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313250/ https://www.ncbi.nlm.nih.gov/pubmed/35885058 http://dx.doi.org/10.3390/biomedicines10071753

Ejemplares similares

Anergic Stupor
por: Dewar, Thomas W.
Publicado: (1884)

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT
por: Dormegny-Jeanjean, Ludovic Christophe, et al.
Publicado: (2023)

Memory T cells are anergic to the superantigen staphylococcal enterotoxin B
Publicado: (1992)

Induction of interleukin 12 responsiveness is impaired in anergic T lymphocytes
Publicado: (1994)

Cd5 Maintains Tolerance in Anergic B Cells
por: Hippen, Keli L., et al.
Publicado: (2000)

Two Cases of Anergic Stupor Treated with Thyroid Gland Extract
por: Bhiday, B. S.
Publicado: (1914)

Early signaling defects in human T cells anergized by T cell presentation of autoantigen
Publicado: (1992)

SYST-27 INTERROGATION OF THE TUMOR IMMUNE MICROENVIRONMENT REVEALS DISTINCT IMMUNOSUPPRESSIVE LANDSCAPES IN GLIOBLASTOMA
por: Weng, Linqian, et al.
Publicado: (2023)

Conversion of CD73(hi)FR4(hi) anergic T cells to IFN-γ–producing effector cells disrupts established immune tolerance
por: Dangi, Anil, et al.
Publicado: (2023)

Measles immunity and immunosuppression
por: Griffin, Diane E
Publicado: (2021)

Repertoire analysis of anergic B cells from patients with systemic lupus erythematosus
por: Longo, NS, et al.
Publicado: (2003)

NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia
por: Märklin, Melanie, et al.
Publicado: (2017)

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2020)

The next wave: immunizing the immunosuppressed
por: Michaelis, Laura C.
Publicado: (2021)

Both Maturation and Survival of Human Dendritic Cells are Impaired in the Presence of Anergic/Suppressor T Cells
por: Frasca, L., et al.
Publicado: (2003)

Human Monocytes Differentiate into Dendritic Cells Subsets that Induce Anergic and Regulatory T Cells in Sepsis
por: Faivre, Valérie, et al.
Publicado: (2012)

Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients
por: Smith, Mia J., et al.
Publicado: (2015)

Anergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged Pathogens
por: Rosenspire, Allen J., et al.
Publicado: (2015)

The Induction and Maintenance of Transplant Tolerance Engages Both Regulatory and Anergic CD4(+) T cells
por: Besançon, Alix, et al.
Publicado: (2017)

Low-Level Expression of CD138 Marks Naturally Arising Anergic B Cells
por: Lee, Sujin, et al.
Publicado: (2022)

Modes of immunosuppression in glioblastoma microenvironment
por: Lehtipuro, Suvi, et al.
Publicado: (2019)

Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood
Publicado: (1992)

Reduced life span of anergic self-reactive B cells in a double- transgenic model
Publicado: (1994)

Regulation of T cell and monocyte activation by human anergic/suppressive CD4 CD25 T cells
por: Taams, LS, et al.
Publicado: (2002)

Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
por: Bacchetta, Rosa, et al.
Publicado: (2014)

Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8(+) T cells
por: Redmond, William L., et al.
Publicado: (2016)

Induction of anergic or regulatory tumor-specific CD4(+) T cells in the tumor-draining lymph node
por: Alonso, Ruby, et al.
Publicado: (2018)

Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies
por: Mejías Sosa, Luis, et al.
Publicado: (2023)

AVIAN IMMUNOSUPPRESSIVE DISEASES AND IMMUNE EVASION
por: SCHAT, KAREL A., et al.
Publicado: (2008)

Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype
por: Sesé, Borja, et al.
Publicado: (2022)

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
por: DeCordova, Syreeta, et al.
Publicado: (2020)

Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma
por: Molina, Maria L., et al.
Publicado: (2019)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Irradiated Tumor Fibroblasts Avoid Immune Recognition and Retain Immunosuppressive Functions Over Natural Killer Cells
por: Yang, Nannan, et al.
Publicado: (2021)

Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas
por: Yin, Anan, et al.
Publicado: (2021)

Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells
Publicado: (1994)

Circulating anergic B cells in the periphery of active systemic lupus erythematosus patients: functional and phenotypic characterization
por: Grammer, A, et al.
Publicado: (2003)

NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation
por: Lindsay, Robin S., et al.
Publicado: (2022)

Comprehensive single-cell analysis reveals novel anergic antigen-presenting cell subtypes in human sepsis
por: Zhang, Tuo, et al.
Publicado: (2023)

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
por: Castella, Barbara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3emjl7nlmjnk72d1t5gi1dg48e